1.
Faith-based health care
by McAdam, David
The Lancet (British edition), 2016, Vol.387 (10017), p.429-430
2.
Walking LIGHTLY
by David McAdam
Environmental Design + Construction, 2010-04-01, Vol.13 (4), p.14
3.
The use of functional communication training to reduce pica
by Napolitano, Deborah A
The journal of speech and language pathology, applied behavior analysis, 2006-12-22, Vol.1 (4), p.25
4.
Walking lightly: a cold-formed, light-gauge steel framing system offers architects a powerful new green tool
by McAdam, David
Environmental design construction, 2010-04-01, Vol.13 (4), p.14
5.
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomise...
by Middleton, Gary, Prof
The lancet oncology, 2014, Vol.15 (8), p.829-840
6.
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
by Bojang, Kalifa A
The Lancet (British edition), 2001-12-08, Vol.358 (9297), p.1927-1934
7.
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an op...
by Earl, Helena M, Dr
The lancet oncology, 2015, Vol.16 (6), p.656-666
8.
In search of global governance for research in epidemics
by Peters, David H
The Lancet (British edition), 2017-10-07, Vol.390 (10103), p.1632-1633
9.
Glycemic Control and Weight Outcomes for Exenatide Once Weekly Versus Liraglutide in Patients with Type 2 Diabetes: A 1-Year Retrospective Cohort Analysis
by McAdam-Marx, Carrie, PhD, RPh
Clinical therapeutics, 2016, Vol.38 (12), p.2642-2651
10.
Approaches for the design of reduced toxicant emission cigarettes
by Dittrich, David J
SpringerPlus, 2014-07-22, Vol.3 (1), p.374-374
11.
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-l...
by Earl, Helena M, Professor
The lancet oncology, 2017, Vol.18 (6), p.755-769
12.
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomise...
by Wasan, Harpreet, MD
The lancet oncology, 2014, Vol.15 (6), p.631-639
13.
287TIME TO INITIAL DETECTION OF ATRIAL FIBRILLATION [AF] WITH IMPLANTABLE CARDIAC MONITOR [ICM] IN CRYPTOGENIC STROKE
by Uzomefuna, Nkechi
Age and ageing, 2016-09, Vol.45 (suppl 2), p.ii1.50-ii12
14.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
by Gaudinski, Martin R Martin R
The Lancet (British edition), 2017-12-05, Vol.391 (10120), p.552-562
15.
Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa
by CONNOLLY, C
AIDS (London), 1999, Vol.13 (12), p.1543-1547
16.
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants
by Klenerman, Paul
Nature (London), 1994-06-02, Vol.369 (6479), p.403-407
17.
Antigenic oscillations and shifting immunodominance in HIV-1 infections
by Nowak, Martin A
Nature (London), 1995-06-15, Vol.375 (6532), p.606-611
18.
New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class I loci
by Watkins, David I
Nature (London), 1992-05-28, Vol.357 (6376), p.329-333
19.
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial
by von Seidlein, Lorenz
The Lancet (British edition), 2000, Vol.355 (9201), p.352-357
20.
A Genomewide Scan for Early-Onset Coronary Artery Disease in 438 Families: The GENECARD Study
by Hauser, Elizabeth R
American journal of human genetics, 2004, Vol.75 (3), p.436-447
